A life extending treatment for some adults with advanced liver cancer has been recommended for use on the NHS by NICE, after a rapid review of guidance published earlier in the year.
Patients with a type of advanced skin cancer will soon have a new treatment option available, after pembrolizumab, also known as Keytruda, was recommended for use on the Cancer Drugs Fund.
NICE has recommended a pioneering cancer treatment, CART-cell therapy, for people under the age of 25 with leukaemia.
A medicine used to treat a rare cancer which occurs predominantly in very young children has been accepted by the Scottish Medicines Consortium (SMC) for routine use in NHS Scotland.
Researchers at the University of Eastern Finland have developed novel antibacterial compounds, focusing on the role of LsrK kinase.
Public Health England will relaunch their 'Keep Antibiotics Working' campaign on 23rd October, with the aim of reducing patient expectations for antibiotics.
A team of UCLA biologists has discovered thousands of four- and five-drug combinations of antibiotics that are more effective at killing harmful bacteria than prevailing views suggest.
A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Currently, very limited therapies are available for this disabling form of the disease.
The Scottish Medicines Consortium (SMC), which advises on newly licensed medicines for use by NHSScotland, has published advice accepting four new medicines, including ovarian and lung cancer treatments.
New research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE).
Seriously ill children battling high-risk neuroblastoma are to be offered a drug which has potential to extend their lives
Kineret (anakinra) has been made available for use in the UK for the treatment of systemic-onset juvenile idiopathic arthritis and adult-onset Still's disease.
A new drinkable supplement that features 11 active ingredient could help patients with long-term conditions such as irritable bowel syndrome.
The Scottish Medicines Consortium (SMC), which advises NHSScotland on newly licensed medicines, has published advice accepting three new medicines.
Adults with type 2 diabetes treated with insulin degludec injection (Tresiba) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin, findings from a real world study have revealed.